Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Novartis CEO unfazed by high-profile clinical failures
Novartis now projects $8 billion in peak sales for Rhapsido across chronic hives and relapsing multiple sclerosis.
Angus Liu
Oct 27, 2026 11:40am
Elrexfio ph. 3 win tees up label expansion in multiple myeloma
Oct 27, 2026 11:15am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
WuXi AppTec has performed well in '26 despite US uncertainties
Oct 27, 2026 10:07am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Lilly fends off Novo’s legal bid to block GLP-1 marketing claims
Oct 27, 2026 10:06am
